BWAY — Brainsway Income Statement
0.000.00%
Last trade - 00:00
- $79.19m
- $32.94m
- $31.79m
- 70
- 39
- 83
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.1 | 22.1 | 29.7 | 27.2 | 31.8 |
Cost of Revenue | |||||
Gross Profit | 18 | 17 | 23.1 | 20 | 23.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 31.6 | 26.9 | 34.7 | 39.9 | 36.7 |
Operating Profit | -8.48 | -4.83 | -5 | -12.7 | -4.96 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.91 | -5.15 | -6.42 | -13 | -3.95 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.3 | -5.38 | -6.46 | -13.3 | -4.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.3 | -5.38 | -6.46 | -13.3 | -4.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.3 | -5.38 | -6.46 | -13.3 | -4.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.504 | -0.24 | -0.207 | -0.405 | -0.13 |
Dividends per Share |